Association of Pre-ESRD Serum Calcium With Post-ESRD Mortality Among Incident ESRD Patients: A Cohort Study
Open Access
- 17 January 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 33 (6), 1027-1036
- https://doi.org/10.1002/jbmr.3391
Abstract
Albumin-corrected serum calcium (cSCa) decline at late stages of chronic kidney disease and rise after dialysis initiation. While hypercalcemia is associated with higher mortality in end-stage renal disease (ESRD), there are scarce data on the impact of pre-ESRD cSCa on post-ESRD mortality. Therefore, we used a large national cohort of 21,826 US veterans with incident ESRD who transitioned to dialysis in all US Department of Veterans Affairs healthcare facilities over 2009-2014 to examine the associations with all-cause and cause-specific post-ESRD mortality of (1) cSCa concentrations averaged over the last six months and (2) its rate of decline during the last 12 months before dialysis initiation. Mean concentrations and median rate of decline of cSCa were 9.3 ± 0.7 mg/dL and -0.15 (interquartile range, -0.39 to 0.07) mg/dL/year, respectively. A total of 9,596 patients died during the follow-up period (mean 1.9 years; total 41,541 patient-years) with an incidence rate of 23.1 per 100 patient-years. There was an independent linear association between higher cSCa with higher mortality (Ptrend Pinteraction <0.001). Patients with faster decline in cSCa showed lower mortality irrespective of baseline cSCa concentrations. These cSCa-mortality associations were stronger for non-cardiovascular vs. cardiovascular death. In conclusion, lower pre-ESRD cSCa and faster decline in cSCa were consistently and linearly associated with better post-ESRD survival among US veterans, especially for non-cardiovascular death. Further studies are needed to determine if correcting hypocalcemia is beneficial or harmful and which intervention is preferred when indicated among patients with incident ESRD. This article is protected by copyright. All rights reservedKeywords
This publication has 55 references indexed in Scilit:
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney DiseaseJama-Journal Of The American Medical Association, 2012
- Active Vitamin D and Acute Respiratory Infections in Dialysis PatientsClinical Journal of the American Society of Nephrology, 2011
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney DiseaseJama-Journal Of The American Medical Association, 2011
- Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis populationNephrology Dialysis Transplantation, 2010
- Effects of Calcium on Cardiovascular Events in Patients with Kidney Disease and in a Healthy PopulationClinical Journal of the American Society of Nephrology, 2010
- Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)American Journal of Kidney Diseases, 2008
- Pitfalls of Measuring Total Blood Calcium in Patients with CKDJournal of the American Society of Nephrology, 2008
- A Comparison of Sevelamer and Calcium-Based Phosphate Binders on Mortality, Hospitalization, and Morbidity in Hemodialysis: A Secondary Analysis of the Dialysis Clinical Outcomes Revisited (DCOR) Randomized Trial Using Claims DataAmerican Journal of Kidney Diseases, 2008
- Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal studyKidney International, 2006